key: cord-0812387-2876b7gm
authors: Golbets, Evgeny; Kaplan, Alon; Shafat, Tali; Yagel, Yael; Jotkowitz, Alan; Awesat, Jenan; Barski, Leonid
title: Secondary organizing pneumonia after recovery of mild COVID‐19 infection
date: 2021-10-05
journal: J Med Virol
DOI: 10.1002/jmv.27360
sha: 5343cad84c6a238a1afac4c69e26d25bab42df24
doc_id: 812387
cord_uid: 2876b7gm

A 36‐year‐old male with diffuse large B‐cell lymphoma on maintenance rituximab therapy presented to the emergency department with high fever and fatigue. A chest X‐ray showed a lobar infiltrate, 40 days before admission the patient suffered from a mild coronavirus disease 2019 (COVID‐19) infection and fully recovered. PCR nasopharyngeal swab was negative for COVID‐19. Comprehensive biochemical, radiological, and pathological evaluation including 18‐fluorodeoxyglucose positron emission tomography with computed tomography and transbronchial lung biopsy found no pathogen or lymphoma recurrence. Treatment for pneumonia with antibiotic and antifungal agents was nonbeneficial. A diagnosis of secondary organizing pneumonia (OP) was made after pneumonia migration and a rapid response to corticosteroids. OP secondary to a viral respiratory infection has been well described. Raising awareness for post‐COVID‐19 OP has therapeutic and prognostic importance because those patients benefit from steroid therapy. We believe the condition described here is underdiagnosed and undertreated by doctors worldwide. Because of the ongoing global pandemic we are now encountering a new kind of patient, patients that have recovered from COVID‐19. We hope that this case may contribute to gaining more knowledge about this growing patient population.

In 2018 follicular lymphoma with monoclonal plasma cell differentiation was diagnosed by excisional lymph node biopsy. 18-Fluorodeoxyglucose (FDG) positron emission tomography (PET) with computed tomography (CT) showed enlarged spleen with lymphadenopathy above and below the diaphragm. The lymphoma was classified as high risk and treated with RCHOP chemotherapy, after 6 cycles, a PET CT shows no evidence of 18F-FDG-avid disease. The patient was assigned to receive maintenance rituximab therapy for the following 2 years. The lymphoma was in remission according to regular hematologic follow-up, including timely PET-CT scans. He had no other comorbidities.

Forty days before admission, the patient suffered from mild COVID-19 infection. The patient suffered from fatigue and high fever, without shortness of breath or cough. A diagnosis of COVID19 was confirmed by a positive PCR swab test. He was completely stable, with no need for oxygen support, he did not receive any treatment other than antipyretic medication. His symptoms lasted for 7 days, and no hospitalization was required. According to local health regulations, after resolution of symptoms and two negative PCR swab tests, the patient was considered recovered. However, a small amount of virus residual and pulmonary infiltration may have remained after recovery, especially in an immunocompromised host. 3, 10 On admission patient's temperature was 39.3°C, blood pressure, 101/57 mmHg; pulse, 88/min; respiratory rate, 16/min; and oxygen saturation, 99% on room air. On physical examination, the patient appeared weak, auscultation of the lungs revealed normal breath sounds, an enlarged spleen was palpated, the remainder of the physical examination was normal. Laboratory workup revealed elevated CRP (7.62 mg/dl) and slight lymphopenia (0.82 10 3 /μl). White blood count, Creatinine, and blood gas were normal. PCR nasopharyngeal swab test for SARS-COV-2 was negative, urine dipstick was negative for leucocyte or nitrites. Chest X-ray demonstrated minimal opacity in the right upper lobe, blood and urine cultures were drawn.

A day later, point of care ultrasound revealed right lung consolidation, a second lung X-ray demonstrated right upper lobe infiltrate, and treatment for community-acquired pneumonia with ceftriaxone was initiated. Nasal swab PCR for Mycoplasma pneumoniae, Chlamydia pneumoniae, Adeno virus and other respiratory infections were negative as well as Legionella pneumophila urinary antigen test.

On Day 3 of admission, the patient continued with symptoms of fatigue, but no dyspnea was present, his fever was 38.9°C, doxycycline therapy was added for atypical pathogens coverage (e.g., coxiella burnetii, mycoplasma pneumonia). Serological testing for Q fever, Brucella, Rickettsia conori, Rickettsia typhi and PCR tests for EBV and CMV were negative. Urine, sputum, aerobic and anaerobic blood culture were taken daily and showed no growth. Sputum samples were negative for mycobacterium, a serum antigen enzymelinked immunosorbent assay (ELISA) for galactomannan was negative, stool sample showed no evidence of bacterial or parasite PCR.

On Day 6 of admission, the patient continued with symptoms of fatigue and high fever without improvement, his oxygen saturation was 95% in ambient air. Chest, abdomen and pelvic CT scan was Table 1 .

Currently, the patient is on anticoagulant therapy and a steroid taper, he went back to work and reports no functional decline.

COVID-19 has a vast spectrum of clinical manifestations, from asymptomatic disease through different degrees of organ dysfunction to death. Immunocompetent patients usually recover after one to 4 weeks, while immunocompromised hosts have an increased risk of prolonged and complicated disease. 3 Clinical features of COVID-19 are well-described, but evidence about the COVID-19 convalescent phase is still evolving. We report the clinical, biomedical, and radiological findings of secondary OP after recovery from a mild COVID-19 in an immunocompromised patient.

Initially, the patient presented with a high fever and a right upper lobe infiltrate and treatment for community-acquired pneumonia was initiated. When the patient did not respond to therapy, we performed an evaluation for other sources of infection, less common and opportunistic. When the patient did not respond to extended-spectrum antibiotics with anti-fungal therapy our differential diagnosis was recurrence of lymphoma, infection, or lung disease. The whole body 18F-FDG PET/CT findings made the likelihood of lymphoma recurrence less likely, so was the possibility of bacterial or fungal infection due to negative laboratory tests and a lack of response to treatment. 

Information for Healthcare Professionals

Clinical outcome of coronavirus disease 2019 in haemato-oncology patients

COVID-19 in immunocompromised hosts: what we know so far

Bronchiolitis obliterans organizing pneumonia: clinical and roentgenological features in 26 cases

Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the

Persistent pneumonic consolidations due to secondary organizing pneumonia in a patient recovering from COVID-19 pneumonia: A case report

Severe organising pneumonia following COVID-19

SARS-CoV-2 organising pneumonia: 'Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?

CDC Guidance for Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings (Interim Guidance). Available online

Detection of SARS-CoV-2 in different types of clinical specimens

The duration of infectiousness of individuals infected with SARS-CoV-2

Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): Duration and key determinants

Persistent detection and infectious potential of sars-cov-2 virus in clinical specimens from covid-19 patients

Association of SARS-CoV-2 genomic load with COVID-19 patient outcomes

Correction to: a systematic review of the clinical utility of cycle threshold values in the context of COVID-19 (infectious diseases and therapy

Organizing pneumonia in patients with severe respiratory failure due to novel A (H1N1) influenza

Idiopathic bronchiolitis obliterans organizing pneumonia with peripheral infiltrates on chest roentgenogram

Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)

Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase

Secondary Organizing Pneumonia After Recovery of Mild COVID-19 Infection

and Leonid Barski: contemplated the main conceptual ideas. Jenan Awesat, Alon Kaplan, and Yael Yagel: preformed literature review. All authors revised the manuscript critically for intellectual content.All authors were part of a multidisciplinary team taking care of the patient. All authors approved the version to be published and participated sufficiently in the work to take public responsibility for the content.

https://orcid.org/0000-0002-2419-7480